Skip navigation
Browsing by Author Guidoboni, M.
Showing results 1 to 1 of 1
| Preview | Issue Date | Title / Name | Author(s) |
| Aug-2023 | First-line, fixed-duration nivolumab plus ipilimumab followed by nivolumab in clinically diverse patient populations with unresectable stage III or IV melanoma: Checkmate 401 | Dummer, R.; Corrie, P; Gutzmer, R.; Meniaway, T. M.; Del Vecchio, M.; Lebbe, C; Guida, M.; Dutriaux, C.; Dreno, B.; Meyer, N.; Ferrucci, P. F.; Dalle, S.; Khattak, M. A.; Grob, J.-J.; Briscoe, K.; Larkin, J.; Mansard, S.; Lesimple, T.; Guidoboni, M.; Sabatini, S.; Richtig, E.; Herbst, R.; Lobo, M.; Askelson, M.; Ascierto, P. A.; Maio, M.; Briscoe, Karen | |
